Nuveen Asset Management, LLC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 92 filers reported holding SERES THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$665,141
-50.6%
279,471
-0.5%
0.00%
Q2 2023$1,345,679
+64071.6%
280,935
-24.0%
0.00%
-100.0%
Q1 2023$2,097
+23.0%
369,695
+21.5%
0.00%0.0%
Q4 2022$1,705
-99.9%
304,387
-34.5%
0.00%0.0%
Q3 2022$2,984,000
+325.1%
464,711
+126.8%
0.00%
Q2 2022$702,000
-62.0%
204,862
-19.3%
0.00%
-100.0%
Q1 2022$1,848,000
-4.0%
253,890
+5.4%
0.00%0.0%
Q4 2021$1,924,000
-46.6%
240,841
-52.5%
0.00%0.0%
Q3 2021$3,606,000
+174.4%
506,516
+78.8%
0.00%
Q2 2021$1,314,000
+27.8%
283,356
+27.9%
0.00%
Q1 2021$1,028,000
-0.9%
221,497
-0.8%
0.00%
Q4 2020$1,037,000
+1.9%
223,330
+1.8%
0.00%
Q3 2020$1,018,000
-17.2%
219,371
-15.0%
0.00%
-100.0%
Q2 2020$1,229,000
+47.9%
258,047
+10.9%
0.00%
Q1 2020$831,000
-3.3%
232,675
-6.6%
0.00%
Q4 2019$859,000
-40.1%
249,034
-30.3%
0.00%
-100.0%
Q3 2019$1,433,000
+436.7%
357,355
+330.3%
0.00%
Q2 2019$267,00083,0490.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders